Cancer

OncLive: PARP Inhibitors Are Under Study as Treatment Options Beyond BRCA-Mutated Breast Cancer

May 10, 2022

Dr. Virginia Kaklamani, Medicine/Mays Cancer Center, is quoted in this article. Dr. Marcela Mazo, Dr. Kate Lathrop and Dr. Heidi Ko, Medicine/Mays Cancer Center, are also mentioned.   Read More



Black patients with cancer fare worse with COVID-19, study shows

April 1, 2022

Structural racism, rather than disease, leads to inequities, authors write Black patients with cancer experienced significantly worse outcomes after COVID-19 diagnosis than non-Hispanic white cancer patients in a study published March 28 in JAMA Network Open. Investigators of the COVID-19 and Cancer Consortium (https://ccc19.org/), which includes more than 125 cancer centers and other organizations, studied […]




Oral Cancer Awareness month: What you need to know

March 31, 2022

The UT Health San Antonio School of Dentistry has partnered with The Oral Cancer Foundation to host The San Antonio Oral Cancer Walk on Saturday, April 23, in observance of the 22nd Annual Oral Cancer Awareness Month.




Black patients with cancer fare worse with COVID-19, study shows

March 28, 2022

Structural racism, rather than disease, leads to inequities, authors write Contacts: Will Sansom, (210) 567-2579, sansom@uthscsa.edu Steven Lee, (210) 450-3823, lees22@uthscsa.edu SAN ANTONIO (March 28, 2022) — Black patients with cancer experienced significantly worse outcomes after COVID-19 diagnosis than non-Hispanic white cancer patients in a study published March 28 in JAMA Network Open. Investigators of […]



San Antonio Business Journal: Delayed by pandemic, construction on $62M cancer center could start this year

March 21, 2022

Ruben Mesa, MD, FACP, executive director of Mays Cancer Center at UT Health San Antonio, is quoted in this story about the city’s support of a new proton therapy center, a partnership between the institution and Proton International.   Read More


Photo of Dr. Ruben Mesa, cancer expert, speaking before a House subcommittee

Mays Cancer Center executive director testifies before House panel about clinical trial diversity

March 18, 2022

Ruben A. Mesa, MD, FACP, professor of medicine and executive director of the Mays Cancer Center at UT Health San Antonio, testified on clinical trial diversity yesterday (March 17, 2022) before the House Committee on Energy and Commerce. The hearing was titled “The Future of Medicine: Legislation to Encourage Innovation and Improve Oversight.” Dr. Mesa […]